1QNZ
NMR structure of the 0.5b anti-HIV antibody complex with the gp120 V3 peptide
SOLUTION NMR
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Bruker | DRX | 800 |
2 | Bruker | DMX | 600 |
NMR Refinement | ||
---|---|---|
Method | Details | Software |
THE STRUCTURE OF THE COMPLEX WAS DETERMINED ALLOWING THE ANTIBODY CDR RESIDUES AND THE COMPLEXED V3 PEPTIDE RESIDUES TO MOVE, WHILE THE ANTIBODY FRAMEWORK WAS HELD FIXED DURING REFINEMENT AND MODELED AS DESCRIBED PREVIOUSLY | X-PLOR |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | |
Conformers Calculated Total Number | |
Conformers Submitted Total Number | 1 |
Additional NMR Experimental Information | |
---|---|
Details | THE STRUCTURE OF THE COMPLEX WAS DETERMINED BY ALLOWING THE CDRS OF THE 0.5B ANTIBODY AND THE V3 PEPTIDE RESIDUES TO MOVE WHILE THE FRAMEWORK OF THE ANTIBODY WAS MODELED AS DESCRIBED. |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | refinement | X-PLOR | 3.8 | BRUNGER |
2 | structure solution | NMRDRAW | ||
3 | structure solution | NMRVIEW | ||
4 | structure solution | XPLOR | 3.8 |